The wait for the corona vaccine in India is about to end. After Russia and China, the UK has also secured the vaccine here. At the same time, three vaccines in India have also sought emergency approval for themselves. The Government of India has said that the regulator will make a decision on this soon and the process of vaccination will be expedited as soon as possible.
Among those seeking emergency approval in India is the US company Pfizer, which has made the mRNA vaccine made by German partner BioNotech. Pfizer's trials have not taken place in India. Because of this, the drug regulator may ask him for trials on some people in India. At the same time, on December 7, the Serum Institute of India (SII) and Bharat Biotech have also sought emergency approval for their vaccines. Both vaccines are in Phase-3 trials in India. SII has tied up with Oxford University / AstraZeneca to produce the vaccine. Its trials in the UK and Brazil have resulted.
According to the Vaccine Landscape of the Government of India, work is currently underway on 9 vaccines in India. There are three vaccines in the pre-clinical stage i.e. currently in labs. Besides, 6 vaccines are in the rough phase of clinical trials. Let's know about the vaccine being made in India ...
1. CoveShield: Decision on application of emergency approval of SII soon.
Who made it: Oxford University and AstraZeneca (UK) have made it together.
Status: AstraZeneca announced the results of its Phase-3 clinical trials on 23 November. Accordingly, when a half and a full dose were given, it was effective up to 90%. At the same time, giving two full doses was 62% effective. SII of Pune in India has signed an agreement to manufacture doses of this vaccine.
When to get and price: Poonawalla's company has applied for emergency approval of this vaccine on 7 December. The government will decide on this soon.
Around 10 million vaccines may be available by February. The government will get a dose of vaccine for 250 rupees and ordinary Indians for 500 rupees.
2. Covaxin: Bharat Biotech has also asked for emergency approval
Who created: Hyderabad-based company Bharat Biotech has created the vaccine in association with the National Institute of Virology (NIV) and the Indian Council of Medical Research (ICMR) and named it - Covaxin.
Status: There have been two phase trials of this vaccine and till now this vaccine has been effective. None of the volunteers has shown serious side-effects. The company has started its phase-3 trials in 25 locations at 25,800 volunteers in November itself. The company has sought emergency approval for the vaccine on 7 December.
When will I get this vaccine if everything happens according to the timeline? So far, the company has not said what its price will be.
3. Sputnik V: Dr. Reddy's Labs started Phase-2/3 trials
Who created: Gamalaya Research Institute of Russia has developed this vaccine with the help of the Russian Direct Investment Fund.
Status: Dr. Reddy's Laboratories Limited and the Russian Direct Investment Fund (RDIF) have started Phase-2/3 clinical trials of Russian Vaccine Sputnik V in India on 1 December. In November, RDIF presented a second interim analysis of Sputnik's clinical trials data. Accordingly, the vaccine remained 91.4% effective 28 days after the first dose and 95% effective 42 days after the first dose.
When to get it and the price: Phase-2/3 trials will take two to three months. The vaccine can be approved after March. The company has given the assurance of its single-dose being around 700 rupees.
4. ZyCov-D: Zydus Cadila Vaccine Ready to Go to Phase-3
Who Made: Ahmedabad-based company Zydus Cadila has created the plasmid DNA vaccine ZyCov-D to protect against Covid-19.
Status: The data of its phase-1 clinical trials has arrived and has given promising results. This has been confirmed by the Data Safety Monitoring Board (DSMB). Phase-2 trials are currently underway, the results of which will be announced soon. The company claims that the results in Phase-2 have also been good.
When to get it and the price: There is a plan to make the vaccine available in the market by the second quarter of 2021. So far, the company has not said what its price will be.
5. NVX-CoV2373: SII to start Phase-3 trials of Novavax vaccine
Who made it: The American company Novavax has built it using protein sub-unit technology. It will be made into the Serum Institute of India (SII) in India.
Status: Phase-3 trials of this vaccine are going on in some other countries including the US. So far it has succeeded in making antibodies. Phase-3 trials of this vaccine are being considered in India.
When to get and price: If everything goes well, then in 2021 this vaccine will be available. By the way, if the results of phase-3 trials in an external country are achieved before the results in India, then serum emergency may seek approval. It has also made similar demands for CoveyShield, an Oxford / AstraZeneca vaccine.
6. Biological E also started phase-1/2 clinical trials
Who created: American company Dynavax Technology Corporation and Houston's Baylor College of Medicine together have created a subunit vaccine candidate.
Status: Hyderabad-based company Biological E has tied up for this vaccine. In November itself, it has received approval from the Drugs Controller General of India (DCGI) to launch Phase-1/2 clinical trials of the Covid-19 subunit vaccine candidate in India. If the vaccine works, then there is a potential to make one billion doses in a year.
When to get and price: This vaccine is expected to be available only after July in 2021. So far, the company has not stated the price.
7. Currently in labs, Genoa Pharma and HDT Biotech vaccine from Pune
Who created: Pune-based Genova Biopharmaceuticals Ltd., in association with the US-based HDT Biotech Corporation, has developed the mRNA vaccine candidate (HGCO19).
Status: This vaccine has shown safety, immunogenicity, neutralization antibody activity in mice and primate models. The company has not yet applied for phase-1/2 clinical trials of its vaccine.
When to get it and the price: Its human trials have not started yet. This vaccine will be available in 2021 only after July. A decision on the price will be made later.
8. Inactivated rabies vector platform: American University has created a vaccine
Who created: Thomas Jefferson University of America has developed this inactivated rabies vector platform vaccine. It will be made in India by Bharat Biotech Company of Hyderabad.
Status: Pre-clinical trials are currently underway for this vaccine. This trial is in the advanced stage. It is expected that the vaccine will soon enter the Human Trials phase.
When to get and the price: Clinical trials have not started yet. In such a situation, it is impossible to tell the time and price.
9. Aurobindo Pharma vaccine currently in pre-clinical stage
Who Made: Hyderabad-based pharmaceutical company Aurobindo Pharma has developed this vaccine.
Status: Currently this vaccine is in the pre-clinical stage. That is, tests are going on in labs only. By the way, the company has reported that the company's vaccine manufacturing factory in Hyderabad may start functioning in May.
When to get and price: It is not possible to say anything at the moment.
Jammu and Kashmir: Two soldiers martyred in Shopian encounter, one terrorist killed, massive search operation going on in the area
An encounter between security forces and terrorists is going on in South Kashmir's Shopian since Saturday morning. Two soldiers have been martyred in the encounter, while one terrorist has been
Yoga fever has taken over the world: America is also enthusiastic; thousands of people performed yoga at Times Square in New York
The enthusiasm of the 10th International Yoga Day is being seen from the country to abroad. A different enthusiasm is being seen among the people about yoga at Times Square in the American city of New
3.4 million people in California at risk of flooding: 2.2 million homes without electricity, many areas submerged; 17 killed so far...
Dangerous storms have wreaked havoc in California, USA for the last two weeks. Since December 26, there have been 6 storms in which 17 people have lost their lives. 90% of the state's population i.e.
Modi said in SCO: Recent developments in Afghanistan are a big challenge, the root cause of these problems is increasing radicalism
Prime Minister Narendra Modi on Friday joined the Shanghai Cooperation Organization (SCO) summit meeting via video conferencing. During his address, he congratulated the people of Tajikistan on the
Kabhi Eid Kabhi Diwali: 'Bachchan Pandey' director leaves Salman's film, Pooja Hegde has a sword on her head too
After losing the title of the biggest brand in Hindi cinema, actor Akshay Kumar is now signing films in his career with little understanding. These hints of Akshay camping in Madhya Pradesh for the
Seema Haider India-Pak Love Story: Threat of 26/11-like attack if Seema Haider does not return to Pakistan, police engaged in investigation
An unidentified person called the Mumbai traffic police control room threatening to carry out 26/11 like attack. According to the police, the Mumbai Police Control Room received a threat call on
Preparation for war against the fourth wave of Corona: Posting of 27 junior doctors in PMCH, you should also be careful
Because of the fear of the fourth wave of Corona, preparations are going on for the Bihar government. From the posting of doctors, resources are being arranged. Every day in the meeting of officials
T20 World Cup: Additional tickets for the two matches of the Indian team will be sold on this day, know complete details.
This year, the T20 World Cup 2024 will be jointly hosted by West Indies and America starting from June 1. Additional tickets for the six T20 World Cup matches to be held in New York will go on sale
Shaaimu SmartFit Pro 1 smartwatch launched in India, these great features will be available in 2799
Shaaimu SmartFit Pro 1: Indian electronics manufacturer Shaaimu has introduced its first smartwatch SmartFit Pro 1 in the market. Shaaimu has specially launched this watch for the youth. SmartFit Pro
PM Modi: PM Modi became emotional while addressing the public, said- It gives great satisfaction to see these things.
Prime Minister Narendra Modi became emotional while addressing the public in Solapur. Actually, under PM Awas Yojana, a residential colony has been constructed in Solapur for the poor people. PM Modi
